ForumIAS LATEST
- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
- The World Health Organisation (WHO) has recommended the use of the HIV drug dolutegravir(DTG) as the preferred first-line and second-line treatment for all populations.
- This drug can also be used for patients including pregnant women and those of childbearing potential.
- Dolutegravir(DTG) which is sold under the brand name Tivicay is an antiretroviral medication used together with other medication to treat HIV/AIDS.
- Studies have shown that DTG is more effective,easier to take and has fewer side effects than alternative drugs.It also has a high genetic barrier to developing drug resistance which is important given the rising trend of resistance.
- In 2019,82 low- and middle-income countries reported to be transitioning to DTG-based HIV treatment.The new recommendations aim at helping more nations improve their HIV policies.
- HIV stands for human immunodeficiency virus. It is the virus that can lead to acquired immunodeficiency syndrome (AIDS), if not treated. There are two main types of the virus: HIV-1 and HIV-2. HIV-2.
- At present there is no effective cure for HIV but HIV can be controlled. The medicine used to treat HIV is called antiretroviral therapy or ART.
